Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer.
暂无分享，去创建一个
V. Conteduca | S. Fogli | U. de Giorgi | M. Del Re | O. Caffo | M. Rizzo | S. Kinspergher | S. Crucitta | E. Verzoni | S. E. Rebuzzi | N. Brighi | T. Beninato | Fiorella Manfredi | Camillo Porta | M. Landriscina | Romano Danesi | Chiara Mercinelli | S. Puglisi | Laura Doni | Giulia Venturi